MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 16, 2004; DOI: 10.1124/mol.104.002287


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.002287v1
66/4/1029    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, S.
Right arrow Articles by Kozasa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, S.
Right arrow Articles by Kozasa, T.


Received for publication May 3, 2004.
Revised July 12, 2004.
Accepted for publication July 13, 2004.

Critical Role of Lysine 204 in Switch I Region of G{alpha}13 for Regulation of p115RhoGEF and LARG

Susumu Nakamura 1, Barry Kreutz 1, Shihori Tanabe 1, Nobuchika Suzuki 1, Tohru Kozasa 1*

1 University of Illinois at Chicago

* Address correspondence to: E-mail: tkozas{at}uic.edu

Abstract

Heterotrimeric G proteins of the G12 family regulate the Rho GTPase through RhoGEFs which contain an amino-terminal RGS domain (RGS-RhoGEFs). Direct regulation of the activity of RGS-RhoGEFs p115 or LARG by G{alpha}13 has previously been demonstrated. However, the precise biochemical mechanism by which G{alpha}13 stimulates the RhoGEF activity of these proteins has not yet been well-understood. Based on the crystal structure of G {alpha}i1 in complex with RGS4, we mutated the G {alpha}13 residue lysine 204 to alanine (G{alpha} 13 K204A) and characterized the effect of this mutation in its regulation of RGS-RhoGEFs p115 or LARG. Compared to wild-type G{alpha}13, G{alpha}13 K204A induced much less serum response factor (SRF) activation when expressed in HeLa cells. Recombinant G{alpha}13 K204A exhibits normal function in terms of nucleotide binding, basal GTP hydrolysis, and formation of heterotrimer with {beta}{gamma}. We found that lysine 204 of G{alpha}13 is important for interaction with the RGS domain of p115 or LARG and for the GAP activity of these proteins. In addition, the K204A mutation of G{alpha}13 impaired its regulation of the RhoGEF activity of p115 or LARG. We conclude that lysine 204 of G{alpha}13 is important for interaction with RGS-RhoGEFs and is critically involved in the regulation of their activity.


Key words: G12,13;other G's, RGS proteins, Cdc42, rho, rac, other small G proteins, Mutagenesis/Chimeric approaches





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics